The Valley Desk

NCT06119581 · Interventional trial

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Overall registry status Recruiting

Phase 3

Conditions Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov